Male-pattern hair loss is not caused by a single “baldness gene.” The androgen receptor, or AR, is the genetic region most strongly and most consistently linked to it.
The receptor is a protein that lets androgens such as testosterone and DHT send signals inside hair follicle cells. Common variations in this gene can shift how sensitive those cells are, but genetic risk is only part of the picture.
The practical question is whether you need to test this gene. For most men, the answer is no. A doctor can usually identify male-pattern hair loss from the scalp exam and the pattern of change.
What the receptor does in hair follicles
The androgen receptor is a protein inside certain cells, including hair follicle cells. It binds to androgen hormones such as testosterone and dihydrotestosterone (DHT). Once DHT binds, the receptor changes shape and triggers signals that affect hair growth.
The AR gene is the DNA instruction for building that receptor. Think of the receptor as a docking point, not as a switch that causes hair loss by itself. The same receptor has normal jobs in many tissues.
In hair follicles, longer or stronger androgen signaling can shorten the active growth phase in men who are genetically susceptible.
How androgens and the androgen receptor gene drive hair loss
Androgens do not attack the hair. In susceptible follicles, they change the hair cycle timing. The result is a shorter growth phase, a smaller follicle, and hairs that come back thinner each cycle.
From testosterone to DHT
The main androgen signal in male-pattern hair loss is DHT. An enzyme in the scalp and other tissues converts some testosterone into DHT. DHT binds the androgen receptor more strongly than testosterone, making it the key trigger in this pathway.
- Testosterone reaches the hair follicle.
- An enzyme converts some testosterone into DHT.
- DHT binds to the androgen receptor inside dermal papilla cells.
- The activated receptor changes the signals that control the hair growth cycle.
- Susceptible follicles spend less time in the growth phase and produce thinner hairs.
What miniaturization does to hair
Follicular miniaturization means the hair follicle shrinks and produces thinner, shorter hair. Over repeated cycles, the hair may become so fine that it is barely visible. This process is gradual, and the follicle is not necessarily scarred or destroyed early on.
The pattern is usually recognizable: the hairline recedes or the crown thins while the sides and back keep more coverage. Recognizing that pattern early helps you and a doctor judge whether the change is likely androgenetic.
Why the AR gene sits on the X chromosome
The AR gene is on the X chromosome. Because men usually have one X chromosome from their mother and one Y chromosome from their father, a man’s AR copy comes from his mother’s side. Older explanations often pointed to the mother’s father.
Still, AR is not the whole story. Many other genetic regions involved in hair loss sit on chromosomes inherited from both parents. That is one reason a family pattern can look different from person to person.
The same X chromosome region also contains a neighboring gene called EDA2R. Researchers are still studying how signals from AR and EDA2R overlap. For now, the region is better understood as a network than as one isolated answer.
What studies show about the androgen receptor gene and hair loss
AR is the most consistently replicated genetic signal in male-pattern hair loss. A 2008 genome-wide study found that men with risk variants at both the AR region and chromosome 20p11 had roughly seven times the odds, and about one in seven men carried both sets.1
Earlier work estimated that variation around AR accounted for 46% of early-onset cases in the patient group studied.2
How common is the key AR variant?
One early study showed why a common AR variant cannot be treated as a diagnosis. The variant appeared in 98.1% of younger balding men and 92.3% of older balding men, but also in 76.6% of men without visible balding.3 The variant is common even when hair is not thinning.
The variant therefore helps explain susceptibility, not a certain outcome. A person can carry it and keep a full head of hair. Another person can have a different combination and still lose hair.
What repeat length does and does not show
A 2012 meta-analysis of eight studies linked the common StuI variant to androgenetic alopecia overall (odds ratio 2.68), with a clearer signal in white populations (odds ratio 2.76), while CAG and GGC repeat lengths showed no clear association.4
A larger 2024 study of 181,217 European men found only a small effect for longer CAG repeats.5 These findings suggest that repeat length is not a reliable predictor of an individual’s future hair loss.
What the key findings mean
Three findings help put the AR region into perspective.
| Finding | What the study reported | What it means |
|---|---|---|
| Common AR variant | Frequent in both balding and non-balding men | It is one influence, not a yes/no result. |
| AR and 20p11 variants together | About 1 in 7 men carried both; odds were around 7 times higher | Genes can act together, but still do not make balding certain. |
| CAG and GGC repeat length | No clear link in a meta-analysis; a later large study found only a small effect | Repeat length is not a useful personal forecast. |
Those numbers describe groups, not one person. They don’t predict how fast an individual’s hair will change, and they don’t mean every man with a risk variant will develop noticeable hair loss.
The main loci are the AR/EDA2R region on the X chromosome and the 20p11 region on chromosome 20, and men who carried risk variants at both had higher odds. Genetic risk is spread across these regions rather than held in AR alone.
What AR testing can and cannot tell you today
Doctors do not need a genetic test to evaluate male-pattern hair loss. In current care, doctors diagnose it based on the pattern, the pace of change, and the exam. AR results may be scientifically interesting, but they are not yet a routine tool for choosing treatment or predicting a person’s outcome.
Some findings suggest that genetic variants may affect treatment response, but a review concludes that no marker has been confirmed as a routine tool for treatment decisions.
- The AR gene plays an important role in genetic risk, but it is not a one-gene verdict.
- Common AR variants appear in many men with full hair and many men with thinning hair.
- Signals near AR/EDA2R and on chromosome 20p11 add more layers to the risk.
- A dermatologist can evaluate the pattern and progression without a genetic test.
Our doctors in Tokyo and Yokohama, Japan, will check whether the change follows the typical male-pattern distribution and explain the next reasonable steps.
Frequently asked questions
- Does the AR gene mean I will lose my hair?
-
No. Common AR variants linked to male-pattern hair loss also appear in many men who keep a full head of hair. Variants in this gene can affect the risk, but other genetic and non-genetic factors also influence whether hair loss develops, when it begins, and how severe it becomes.
- Is the AR gene inherited from my mother’s side?
-
Yes. Because the AR gene is on the X chromosome, men usually inherit their copy from their mother. Many other genes involved in hair loss come from both parents, which is why both sides of the family can be relevant.
- Should I get a genetic test to check my AR variants?
-
For most men, the answer is no. AR testing isn’t a routine tool in hair loss care, and repeat-length results haven’t been shown to predict an individual man’s outcome well. A dermatologist can often learn more from the scalp exam and the pattern of change.
- What should I do if I notice early thinning?
-
See a dermatologist who treats hair loss. The doctor can examine your scalp, confirm whether the pattern is androgenetic, and check for other causes such as low iron, thyroid disease, or scalp conditions. Early evaluation gives you a clearer baseline for deciding what to watch and when to treat.
References
1. Richards, J. B., Yuan, X., Geller, F., Waterworth, D., Bataille, V., Glass, D., Song, K., Waeber, G., Vollenweider, P., Aben, K. K., Kiemeney, L. A., Walters, B., Soranzo, N., Thorsteinsdottir, U., Kong, A., Rafnar, T., Deloukas, P., Sulem, P., Stefansson, H., … Mooser, V. (2008). Male-pattern baldness susceptibility locus at 20p11. Nature Genetics, 40(11), 1282-4. https://doi.org/10.1038/ng.255
2. Hillmer, A. M., Hanneken, S., Ritzmann, S., Becker, T., Freudenberg, J., Brockschmidt, F. F., Flaquer, A., Freudenberg-Hua, Y., Jamra, R. A., Metzen, C., Heyn, U., Schweiger, N., Betz, R. C., Blaumeiser, B., Hampe, J., Schreiber, S., Schulze, T. G., Hennies, H. C., Schumacher, J., … Nothen, M. M. (2005). Genetic variation in the human androgen receptor gene is the major determinant of common early-onset androgenetic alopecia. American Journal of Human Genetics, 77(1), 140-8. https://doi.org/10.1086/431425
3. Ellis, J. A., Stebbing, M., & Harrap, S. B. (2001). Polymorphism of the androgen receptor gene is associated with male pattern baldness. The Journal of Investigative Dermatology, 116(3), 452-5. https://doi.org/10.1046/j.1523-1747.2001.01261.x
4. Zhuo, F. L., Xu, W., Wang, L., Wu, Y., Xu, Z. L., & Zhao, J. Y. (2012). Androgen receptor gene polymorphisms and risk for androgenetic alopecia: a meta-analysis. Clinical and Experimental Dermatology, 37(2), 104-11. https://doi.org/10.1111/j.1365-2230.2011.04186.x
5. Sasako, T., Ilboudo, Y., Liang, K. Y. H., Chen, Y., Yoshiji, S., & Richards, J. B. (2024). The Influence of Trinucleotide Repeats in the Androgen Receptor Gene on Androgen-related Traits and Diseases. The Journal of Clinical Endocrinology and Metabolism, 109(12), 3234-3244. https://doi.org/10.1210/clinem/dgae302
Lolli, F., Pallotti, F., Rossi, A., Fortuna, M. C., Caro, G., Lenzi, A., Sansone, A., & Lombardo, F. (2017). Androgenetic alopecia: a review. Endocrine, 57(1), 9-17. https://doi.org/10.1007/s12020-017-1280-y
Heilmann-Heimbach, S., Hochfeld, L. M., Henne, S. K., & Nöthen, M. M. (2020). Hormonal regulation in male androgenetic alopecia-Sex hormones and beyond: Evidence from recent genetic studies. Experimental Dermatology, 29(9), 814-827. https://doi.org/10.1111/exd.14130
Gupta, A. K., Dennis, D. J., Economopoulos, V., & Piguet, V. (2026). The Genetic Landscape of Androgenetic Alopecia: Current Knowledge and Future Perspectives. Biology, 15(2). https://doi.org/10.3390/biology15020192





